Immunosuppressive therapy of biopsy proved immune-mediated lymphocytic myocarditis in the virus-negative and virus-positive patients
Immunosuppressive therapy of biopsy proved immune-mediated lymphocytic myocarditis in the virus-negative and virus-positive patients
复制标题
DOI:
10.1016/j.carpath.2020.107260
复制
发表时间:
2020-11-01
影响因子:
3.7
通讯作者:
Fomin, Victor
中科院分区:
文献类型:
--
作者:
Blagova, Olga;Nedostup, Alexander;Fomin, Victor
Purpose: to study the effect of immunosupressive therapy (IST) in the virus-negative and virus-positive patients with immune-mediated myocarditis.Methods: in 60 patients (45 male, 46.7 +/- 11.8 years, mean LV EDD, 6.7 +/- 0.7 cm, EF 26.2 +/- 9.1%) active/borderline myocarditis was verified by endomyocardial biopsy (n = 38), intraoperative biopsy (n = 10), examination of explanted heart (n = 3) and autopsy (n = 9). Indications for IST determined based on histological, immune activity. The follow-up was 19.0 [7.25; 40.25] months.Results: The viral genome in the myocardium was detected in 32 patients (V+ group), incl. parvovirus B19 in 23. The anti-heart antibody level was equally high in the V+ and V- patients. Antiviral therapy was administered in 24 patients. IST (in 22 V+ and 24 V- patients) include steroids (n = 40), hydroxy-chloroquine (n = 20), azathioprine (n = 21). The significant decrease of LV EDD (6.7 +/- 0.7 to 6.4 +/- 0.8), PAP (48.9 +/- 15.5 to 39.4 +/- 11.5 mm Hg, p